Doctor of Podiatric Medicine Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Maureen Caldwell

Podiatrist, Primary Podiatric Medicine Victoria, TX Doctor of Podiatric Medicine

NPI 1568464634 CMS profile 252831

116 Imperial Dr, Ste A, Victoria, TX 77901

Open in the dashboard

General payments

$3,400

129 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Maureen Caldwell of Victoria, TX is reported in the CMS Open Payments database as having received $3,400 across 129 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 82nd percentile of Podiatrist, Primary Podiatric Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $548 27
2024 General $169 12
2023 General $546 23
2022 General $387 12
2021 General $532 23
2020 General $555 18
2019 General $664 14

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Maureen Caldwell
  • Podiatrist, Primary Podiatric Medicine median
  • Middle half of Podiatrist, Primary Podiatric Medicine
  • National median

In program year 2025, general payments to Maureen Caldwell were reported at $548. Among 368 Podiatrist, Primary Podiatric Medicine profiles paid that year, the median was $232 and the middle half received between $88 and $586.

Show as a table
Year Maureen Caldwell Podiatrist, Primary Podiatric Medicine median Middle half National median
2019 $664 $166 $51–$513 $163
2020 $555 $108 $33–$249 $114
2021 $532 $147 $52–$377 $132
2022 $387 $188 $66–$551 $149
2023 $546 $195 $70–$509 $160
2024 $169 $209 $59–$508 $164
2025 $548 $232 $88–$586 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Organogenesis Inc. $1,563 85 payments
  2. Crossroads Extremity Systems, LLC $334 4 payments
  3. Smith+Nephew, Inc. $246 9 payments
  4. Nevro Corp. $229 5 payments
  5. Musculoskeletal Transplant Foundation Inc. $182 2 payments
  6. Stryker Corporation $177 2 payments
  7. Melinta Therapeutics, Inc. $99 2 payments
  8. Pacira Pharmaceuticals Incorporated $87 1 payment
  9. Medline Industries, Inc. $84 1 payment
  10. Wright Medical Technology, Inc. $65 2 payments
  11. Other $335 16 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $3,400 129 payments
Products named General payments · program years 2019–2025
  1. Puraply $772 46 payments
  2. Affinity $206 6 payments
  3. Senza $197 4 payments
  4. CYGNUS DUAL $187 11 payments
  5. ANCHORAGE $170 1 payment
  6. PURAPLY WOUND MATRIX $160 2 payments
  7. APLIGRAF $137 1 payment
  8. GrafixPL $132 2 payments
  9. GRAFIX $132 2 payments
  10. Stravix $132 2 payments
  11. Other $1,323 57 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 6 drugs

Part D claims

104

Median for Podiatry: 160

Drug cost

$1,926

Median for Podiatry: $2,368

Branded share of claims

15.4%

Median for Podiatry: 12.7%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Clotrimazole Generic 21 $598
Ammonium Lactate Generic 23 $468
Terbinafine Hcl Generic 21 $355
Ciclopirox Generic 12 $323
Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav Brand 16 $151
Meloxicam Generic 11 $30

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 14,093 Part D prescribers listed as Podiatry; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 41 billing codes

Paid by Medicare

$122,530

Medicare's payments for the services billed

Medicare patients

322

Average age 76

Services billed

1,193

190 women, 132 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 64%
Diabetes 54%
Ischemic heart disease 33%
Chronic kidney disease 33%
Depression 23%
Heart failure 21%
Atrial fibrillation 18%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

129 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Podiatrist, Primary Podiatric Medicine in Texas

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record